To include your compound in the COVID-19 Resource Center, submit it here.

DC-RTS-IL-12: Interim Phase Ib data

Interim data from the ongoing, open-label, U.S. Phase Ib RTS-M101B trial in 7 patients with unresectable stage

Read the full 174 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE